Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Post by golfyetion Nov 13, 2023 1:26pm
157 Views
Post# 35732359

ACB vs DN

ACB vs DN

ACB sales TTM $264 M  -- Market valuation = $280 Million

DN Sales TTM  $ 68 M  -- Market valuation =   $    5 Million

ACB has (only) 3.88 times DN's sales yet ACB enjoys (not 3.88 times market value but) 58 TIMES DN's market value.

It would great if DN also reported similar positive adjusted ebitda.  The market valuation disparity would be even more ludicrous.

Time to get noticed Delta 9 !   And time to get your maket valuation to the 1.1 times sales level that ACB enjoys and in doing so get yourself a more peer-like market valuation more in the $75-80 Million dollar range i.e., a share price north of $0.50.  With respectable growth over the next five years that's the minimum that the company is really worth in my opinion.  If I am right its a near 15 bagger for those who can buy shares down here.

 

<< Previous
Bullboard Posts
Next >>